Share This Link

Pitocin is a uterotonic medication that is used to prevent postpartum hemorrhage by inducing contractions between delivery of the baby and the placenta.

It is not as effective as carboprost for treating severe bleeding.

Methylergonovine maleate (Methergine) is another uterotonic medication that causes sustained uterine contractions and vasoconstriction.

However, it is contraindicated in patients with hypertension, which is a common complication of pregnancy.

Misoprostol (Cytotec) is a synthetic prostaglandin that can be used to prevent or treat postpartum hemorrhage by causing uterine contractions.However, it is less effective than carboprost and has more side effects such as fever, diarrhea and shivering.

Oxytocin is the first-line drug for preventing and treating postpartum hemorrhage due to uterine atony, but it may not be enough to enhance uterine tone in some cases.

Methylergonovine maleate is an ergot alkaloid that causes sustained uterine contractions, but it has more side effects and contraindications than oxytocin, such as hypertension, nausea, vomiting and headache.

Misoprostol (Cytotec) is a synthetic prostaglandin E1 analogue that can be used orally, sublingually, rectally or vaginally to induce uterine contractions, but it is less effective and has more adverse effects than oxytocin or carboprost tromethamine.

Pitocin (oxytocin) is a medication that stimulates uterine contractions and is used to prevent or treat uterine atony, which is the most common cause of postpartum hemorrhage.

However, it does not inhibit fibrinolysis.

Carboprost tromethamine (Hemabate) is a prostaglandin that also stimulates uterine contractions and is used to treat postpartum hemorrhage due to uterine atony.

However, it does not inhibit fibrinolysis.

Methylergonovine maleate (Methergine) is an ergot alkaloid that also stimulates uterine contractions and is used to treat postpartum hemorrhage due to uterine atony.

However, it does not inhibit fibrinolysis.

Misoprostol (Cytotec) is another prostaglandin that also stimulates uterine contractions and is used to prevent or treat postpartum hemorrhage due to uterine atony.

However, it does not inhibit fibrinolysis.

Oxytocin is the first-line medication for preventing and treating postpartum hemorrhage due to uterine atony, but it may not be effective in some cases.

Methylergonovine maleate (Methergine) is an ergot alkaloid that also induces uterine contractions, but it has more side effects and contraindications than prostaglandins.

Misoprostol (Cytotec) is another prostaglandin that can be used for postpartum hemorrhage, but it is less effective and has more adverse effects than carboprost tromethamine.

Pitocin (oxytocin) is a uterotonic medication that stimulates uterine contractions and reduces bleeding from uterine atony, which is the most common cause of postpartum hemorrhage.

However, it does not directly replace blood volume or clotting factors.

Hemabate (carboprost tromethamine) is another uterotonic medication that can be used to treat postpartum hemorrhage caused by uterine atony, especially if oxytocin is ineffective or contraindicated.

However, it also does not directly replace blood volume or clotting factors.

Methergine (methylergonovine maleate) is a third uterotonic medication that can be used to treat postpartum hemorrhage caused by uterine atony, especially if oxytocin and carboprost are ineffective or contraindicated.

However, it also does not directly replace blood volume or clotting factors.